Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


Gentrack's Docking defends prospectus as FMA asks questions

Gentrack's Docking defends prospectus as FMA asks questions

By Jonathan Underhill

Aug. 6 (BusinessDesk) - Gentrack Group chief executive James Docking says the company's prospectus was the result of thorough due diligence and expert advice, and the subsequent cut to guidance reflected the complex nature of its airport and utility software projects.

The shares last traded at $2.12, below the initial public offering price of $2.40 in June, having slumped on Aug. 1 when the company said it wouldn't meet its prospectus forecasts for 2014 sales and profit because of a payment dispute and a delay to a contract. The company said today the hold-ups, involving two large utility customers, became apparent only shortly before the Aug. 1 announcement.

"We spent a lot of money with advisers through due diligence," Docking told BusinessDesk. "The market hates uncertainty and that's the nature of it," he said of the sell off in the stock. "We do big, complex projects and they are notoriously difficult to forecast."

In the case of the delayed contract, Docking said he has "a strong belief we will get it signed soon." The payment dispute was following the terms set out in that contract, which lead to mediation, and related to clauses allowing the company to claim additional costs. As a result, revenue from the contract would be booked in the next financial year.

"It's a learning curve," he said of the way the shares were punished. "I regret we had to make the announcement" but the company had an obligation to go the market as soon as it became clear it wouldn't meet forecasts, he said.

Docking confirmed that the Financial Markets Authority has questioned the company over its disclosures, which it had expected would happen. He wasn't overly concerned about the regulator's interest.

The airport and utility software company's stock surged on their debut on the NZX on June 25 after an IPO in which shareholders including chairman John Clifford and Docking sold $63 million of existing shares along with $36 million of new capital used to repay debt and IPO costs. While the company immediately briefed analysts, executives avoided public comment until today's statement.

The company doesn't expect to have to drop its forecast dividend of $2.6 million to be paid in December or lower guidance for 2015 from its prospectus forecast.

(BusinessDesk)

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Media: Julian Wilcox Leaves Māori TV

Māori Television has confirmed the resignation of Head of News and Production Julian Wilcox. Mr Maxwell acknowledged Mr Wilcox’s significant contribution to Māori Television since joining the organisation in 2004. More>>

ALSO:

Genetics: New Heat Tolerant Cow Developed

Hamilton, New Zealand-based Dairy Solutionz Ltd has led an expert genetics team to develop a new dairy cow breed conditioned to thrive in lower elevation tropical climates and achieve high milk production under heat stress. More>>

Fractals: Thousands More Business Cards Needed To Build Giant Sponge

New Zealand is taking part in a global event this weekend to build a Menger Sponge using 15 million business cards but local organisers say they are thousands of business cards short. More>>

Scoop Business: NZ Net Migration Rises To Annual Record In September

New Zealand’s annual net migration rose to a record in September, beating government forecasts, as the inflow was spurred by student arrivals from India and Kiwis returning home from Australia. More>>

ALSO:

Scoop Business: Fletcher To Close Its Christchurch Insulation Plant, Cut 29 Jobs

Fletcher Building, New Zealand’s largest listed company, will close its Christchurch insulation factory, as it consolidates its Tasman Insulations operations in a “highly competitive market”. More>>

ALSO:

Scoop Business: Novartis Adds Nine New Treatments Under Pharmac Deal

Novartis New Zealand, the local unit of the global pharmaceuticals firm, has added nine new treatments in a far-ranging agreement with government drug buying agency, Pharmac. More>>

ALSO:

Crown Accounts: English Wary On Tax Take, Could Threaten Surplus

Finance Minister Bill English is warning the tax take may come in below forecast in the current financial year, as figures released today confirm it was short by nearly $1 billion in the year to June 30 and English warned of the potential impact of slumping receipts from agricultural exports. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand

Mosh Social Media
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news